About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
https://www.weizmann-usa.org/news-media/feature-stories/a-year-of-achievements-and-advances/
Jan 18, 2017... The prostate cancer therapy Tookad® is the product of a decades-long cross-disciplinary partnership between a plant scientist, Prof. Avigdor Scherz, and a biochemist, Prof. Yoram Salomon. The chlorophyll-based method destroys the tumor but not the healthy tissue nearby – and without the quality-of-life impacts of other prostate cancer treatments. This past year, Mexico approved Tookad® for treatment of early stage prostate cancer. Europe and Israel are nearing approval, and late-stage clinical trials are ongoing at New York’s Memorial Sloan Kettering Cancer Center.
Jun 06, 2016...
Dr. Bruce Lasker of Pfizer and Dr. Berta Strulovici, head of the G-INCPM, on the Weizmann campus
REHOVOT, ISRAEL—June 6, 2016—The Weizmann Institute of Science in Rehovot, Israel, and Yeda Research and Development Co., Ltd., its commercial arm, announced this week that they have entered a multi-year arrangement with Pfizer Inc. The arrangement will entail collaboration at the newly established National Drug Discovery Institute (DDI) in the Nancy and Stephen Grand Israel National Center for Personalized Medicine (G-INCPM), which is part of the Weizmann Institute and located on its campus. Pfizer will be supporting the G-INCPM by placing a Pfizer medicinal chemist (rotating on a yearly basis) at the Institute to assist with advancing target selection and high-throughput screening, as well as leading development campaigns for programs that enter the DDI. If projects of mutual interest – those that hold promise in addressing unmet medical needs – are identified, Pfizer and Yeda will evaluate the potential for research and development agreements.
Nov 01, 2008...
This year's top institutions give researchers more than a place to do great science. They offer the opportunity to nurture, and be nurtured in return.
Starting a new job isn’t easy, even if you are Ron Weiss, an innovator in the emerging field of synthetic biology. When Weiss arrived at Princeton University seven years ago, straight from completing his PhD at the Massachusetts Institute of Technology, the young bioengineer had never been a principal investigator, much less set up a lab from scratch. Fortunately, as soon as Weiss arrived at Princeton, ranked No. 2 on this year’s Best Places to Work in Academia survey, Jim Sturm, a senior electrical engineer, was appointed as his “big brother” by the department chair. “I could turn to him for questions about grants, managing the lab, trying to think about research directions,” says Weiss, “It was wonderful.”
Feb 05, 2020... Jerusalem, January 27, 2020 — The Blavatnik Family Foundation, the New York Academy of Sciences, and the Israel Academy of Sciences and Humanities (IASH) announced today the 2020 Laureates of the third annual Blavatnik Awards for Young Scientists in Israel. The Blavatnik Awards recognize outstanding, innovative scientists at the early stages of their careers for both their extraordinary achievements and their promise for future discoveries. The prizes are awarded to researchers aged 42 and younger for their groundbreaking work in the disciplines of Life Sciences, Chemistry, and Physical Sciences & Engineering.
May 26, 2016...
(l-r) Weizmann Institute of Science President Prof. Daniel Zajfman, Prof. Victor Malka, and École Polytechnique President Jacques Biot
Jacques Biot, President of École Polytechnique (Palaiseau, France), and Prof. Daniel Zajfman, President of the Weizmann Institute of Science (Rehovot, Israel), signed a cooperation agreement to develop and promote collaboration in higher education and research between the two institutions.
Nov 26, 2019... Indian researchers benefit from not just the theoretical background that an Israel education provides, but also the world-class infrastructure that is an intrinsic part of the system. This, says Avraham Yaron, professor at the Department of Biomolecular Sciences, Weizmann Institute of Science, “is largely because of Israel’s global reputation as a startup nation with innovation and technology at its core.”
Jun 26, 2012...
REHOVOT, ISRAEL—June 26, 2012—The Weizmann Institute of Science has announced the launch of two new applications for iPad and Android tablet devices – one for its quarterly Hebrew magazine Hamachon, and another for its online Interface magazine (English). These are among the very first digital magazines in Israel.
These easy-to-read quarterly magazines are geared toward the general public, featuring cutting-edge news and discoveries from the Weizmann Institute of Science, including a diverse range of topics, from cancer to genetics, astrophysics, alternative energy, computer science, archaeology and more.
Oct 19, 2015...
Richard Price
The 800 guests at the Fairmont Hotel were restless when Richard Price took the stage to accept his honors from the Weizmann Institute of Science, a research university in Israel supported by numerous Chicago business executives.
The crowd already had sat through a Q&A panel of scientists talking about the Israel-based organization's work—all while the Cubs game was being broadcast from New York.
Apr 12, 2018...
On April 11, 2018, American Committee supporters from across the country tuned in for CEO Marshall S. Levin's most recent conference call focused on “Science at the Leading Edge: Latest Breakthroughs from the Weizmann Institute of Science.”
As one of the deadliest flu seasons comes to a close, Mr. Levin informed the audience that Weizmann scientists have developed a universal flu vaccine that may provide full protection from all strains of the virus. The vaccine is now in late-stage clinical trials.
Apr 05, 2017...
Weizmann alumnus Dr. Jeffrey Rothenberg wears many hats. Over the course of a single day, you might find him seeing patients, leading an executive hospital meeting, teaching medical students, or delivering newborns. You might also find him practicing an entirely different occupation: glassblowing.
An accomplished obstetrician-gynecologist, a celebrated professor, and a prolific artist, Dr. Rothenberg says his vocations and his avocation are integral to who he is. And while friends, family, and colleagues marvel at his ability to use both sides of his brain, he sees the two as intertwined. The arts and humanities, he believes, nurture skills such as observation, introspection, and empathy—all of which make physicians better healers.
©2023 American Committee for the Weizmann Institute of Science
FOR THE FOURTH CONSECUTIVE YEAR
